HIV-1 Integrase Inhibitors
Journal of Medicinal Chemistry, 2008, Vol. 51, No. 2 259
(4) Pommier, Y.; Johnson, A. A.; Marchand, C. Integrase inhibitors to
treat HIV/AIDS. Nat. ReV. Drug DiscoVery 2005, 4, 236–248.
(5) Craigie, R.; Mizuuchi, K.; Bushman, F. D.; Engleman, S. A. A rapid
in vitro assay for HIV DNA integration. Nucleic Acid Res. 1991, 19,
2729–2734.
(6) Pommier, Y.; Neamati, N. Inhibitors of human immunodeficiency virus
integrase. AdV. Virus Res. 1999, 52, 427–458.
(7) Witvrouw, M.; Fikkert, V.; Vercammen, J.; Van Maele, B.; Engel-
borghs, Y.; Debyser, Z. Identification of authentic inhibitors of HIV-1
integration. Curr. Med. Chem. Anti-Infect. Agents 2005, 4, 153–165.
(8) Wai, J. S.; Egbertson, M. S.; Payne, L. S.; Fisher, T. E.; Embrey,
M. W.; Tran, L. O.; Melamed, J. Y.; Langford, H. M.; Guare, J. P.,
Jr.; Zhuang, L.; Grey, V. E.; Vacc, J. P.; Holloway, M. K.; Naylor-
Olsen, A. M.; Hazuda, D. J. F., P. J.; Wolfe, A. L.; Stillmock, K. A.;
Schleif, W. A.; Gabryelski, L. J.; Young, S. D. 4-Aryl-2,4-dioxobu-
tanoic acid inhibitors of HIV-1 integrase and viral replication in cells.
J. Med. Chem. 2000, 43, 4923–4926.
(9) Hazuda, D. J.; Young, S. D.; Guare, J. P.; Anthony, N. J.; Gomez,
R. P.; Wai, J. S.; Vacca, J. P.; Handt, L.; Motzel, S. L.; Klein, H. J.;
Dornadula, G.; Danovich, R. M.; Witmer, M. V.; Wilson, K. A. A.;
Tussey, L.; Schleif, W. A.; Gabryelski, L. S.; Jin, L.; Miller, M. D.;
Casimiro, D. R.; Emini, E. A.; Shiver, J. W. Integrase inhibitors and
cellular immunity suppress retroviral Replication in rhesus macaques.
Science 2004, 305, 528–532.
(10) Guare, J. P.; Wai, J. S.; Gomez, R. P.; Anthony, N. J.; Jolly, S. M.;
Cortes, A. R.; Vacca, J. P.; Felock, P. J.; Stillmock, K. A.; Schleif,
W. A.; Moyer, G.; Gabryelski, L. J.; Jin, L.; Chen, I. W.; Hazuda,
D. J.; Young, S. D. A series of 5-aminosubstituted 4-fluorobenzyl-8-
hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors.
Bioorg. Med. Chem. Lett. 2006, 16, 2900–2904.
(11) Crescenzi, B.; Gardelli, C.; Muraglia, E.; Nizi, E.; Orvieto, F.; Pace,
P.; Pescatore, G.; Petrocchi, A.; Poma, M.; Rowley, M.; Scarpelli,
R.; Summa, V. Preparation of N-substituted hydroxypyrimidinone
carboxamide inhibitors of HIV integrase. PCT Application: WO
2003035077, 2003; Chem. Abstr. AN 2003: 334912.
(12) Belyk, K. M.; Morrison, H. G.; Jones, P.; Summa, V. Preparation of
N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-
1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-dihydropyrimi-
dine-4-carboxamide potassium salts as HIV integrase inhibitors. PCT
Application: WO2006060712, 2006; Chem. Abstr. AN 2006: 544674.
(13) Markowitz, M.; Morales-Ramirez, J. O.; Nguyen, B.-Y.; Kovacs,
C. M.; Steigbigel, R. T.; Cooper, D. A.; Liporace, R.; Schwartz, R.;
Isaacs, R.; Gilde, L. R.; Wenning, L.; Zhao, J.; Teppler, H. Antiret-
roviral activity, pharmacokinetics, and tolerability of MK-0518, a novel
inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in
treatment-Naive HIV-1-infected individuals. JAIDS, J. Acquired
Immune Defic. Syndr. 2006, 43, 509–515.
(14) Pace, P.; Di Francesco, M. E.; Gardelli, C.; Harper, S.; Muraglia, E.;
Nizi, E.; Orvieto, F.; Petrocchi, A.; Poma, M.; Rowley, M.; Scarpelli,
R.; Laufer, R.; Gonzalez Paz, O.; Monteagudo, E.; Bonelli, F.; Hazuda,
D.; Stillmock, K. A.; Summa, V. Dihydroxypyrimidine-4-carboxam-
ides as novel potent and selective HIV integrase inhibitors. J. Med.
Chem. 2007, 50, 2225–2239.
Pommier, Y. Metal-dependent inhibition of HIV-1 integrase. J. Med.
Chem. 2002, 45, 5661–5670.
(21) Corey, E. J.; Bhattacharyya, S. Total synthesis of enterobactin,
macrocyclic iron transporting agent of bacteria. Tetrahedron Lett. 1977,
45, 3919–3922.
(22) Gramer, C. J.; Raymond, K. N. A streamlined synthesis for 2,3-
dihydroxyterephthalamides. Org. Lett. 2001, 3, 2827–2830.
(23) Zhao, H.; Burke, T. R., Jr. Pentafluorophenyl ester activation for the
preparation of N,N′-diaroylhydrazines. Tetrahedron 1997, 53, 4219–
4230.
(24) Napolitano, E.; Spinelli, G.; Fiaschi, R.; Marsili, A. A simple total
synthesis of the isoindolobenzazepine alkaloids lennoxamine and
chilenamine. J. Chem. Soc., Perkin Trans. 1 1986, 785–787.
(25) Napolitano, E.; Giannone, E.; Fiaschi, R.; Marsili, A. Influence of
alkoxyalkyl substituents In the regioselective lithiation of the benzene
ring. J. Org. Chem. 1983, 48, 3653–3657.
(26) Sahakitpichan, P.; Ruchirawat, S. A practical and highly efficient
synthesis of lennoxamine and related isoindolobenzazepines. Tetra-
hedron 2004, 60, 4169–4172.
(27) Jin, H.; Cai, R. Z.; Schacherer, L.; Jabri, S.; Tsiang, M.; Fardis, M.;
Chen, X.; Chen, J. M.; Kim, C. U. Design, synthesis, and SAR studies
of novel and highly active tri-cyclic HIV integrase inhibitors. Bioorg.
Med. Chem. Lett. 2006, 16, 3989–3992.
(28) Verschueren, W. G.; Dierynck, I.; Amssoms, K. I. E.; Hu, L.; Boonants,
P. M. J. G.; Pille, G. M. E.; Daeyaert, F. F. D.; Hertogs, K.; Surleraux,
D. L. N. G.; Wigerinck, P. B. T. P. Design and optimization of tricyclic
phthalimide analogues as novel inhibitors of HIV-1 integrase. J. Med.
Chem. 2005, 48, 1930–1940.
(29) Following submission of this manuscript a conceptually-related series
of HIV-1 integrase inhibitors was reported: Wai, J. S.; Kim, B.; Fisher,
T. E.; Zhuang, L.; Embrey, M. W.; Williams, P. D.; Staas, D. D.;
Culberson, C.; Lyle, T. A.; Vacca, J. P.; Hazuda, D. J.; Felock, P. J.;
Schleif, W. A.; Gabryelski, L. J.; Jin, L.; Chen, I. W.; Ellis, J. D.;
Mallai, R.; Young, S. D. Dihydroxypyridopyrazine-1,6-dione HIV-1
integrase inhibitors. Bioorg. Med. Chem. Lett. 2007, 17, 5595–5599.
(30) Zhuang, L.; Wai, J. S.; Embrey, M. W.; Fisher, T. E.; Egbertson, M. S.;
Payne, L. S.; Guare, J. P., Jr.; Vacca, J. P.; Hazuda, D. J.; Felock,
P. J.; Wolfe, A. L.; Stillmock, K. A.; Witmer, M. V.; Moyer, G.;
Schleif, W. A.; Gabryelski, L. J.; Leonard, Y. M.; Lynch, J. J., Jr.;
Michelson, S. R.; Young, S. D. Design and synthesis of 8-hydroxy-
[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and
in infected cells. J. Med. Chem. 2003, 46, 453–456.
(31) Oh, J.; McWilliams, M. J.; Julias, J. G.; Hughes, S. H. Mutations in
the U5 adjacent to the primer binding site affect tRNA cleavage by
HIV-1 RT in ViVo. J. Virol. [Online early access]. Published Online:
Nov 7, 2007.
(32) Julias, J. G.; Boyer, P. L.; McWilliams, M. J.; Alvord, W. G.; Hughes,
S. H. Mutations at position 184 of human immunodeficiency virus
type-1 reverse transcriptase affect virus titer and viral DNA synthesis.
Virology 2004, 322, 13–21.
(33) Petropolous, C. J.; Parkin, N. T.; Limoli, K. L.; Lie, Y. S.; Wrin, T.;
Huang, W.; Tian, H.; Smith, D.; Winslow, G. A.; Capon, D. J.;
Whitcomb, J. M. A novel phenotypic drug susceptibility assay for
human immunodeficiency virus type 1. Antimicrob. Agents Chemother.
2007, 44, 920–928.
(34) Leh, H.; Brodin, P.; Bischerour, J.; Deprez, E.; Tauc, P.; Brochon,
J. C.; LeCam, E.; Coulaud, D.; Auclair, C.; Mouscadet, J. F.
Determinants of Mg2+-dependent activities of recombinant human
immunodeficiency virus type 1 integrase. Biochemistry 2000, 39, 9285–
9294.
(35) Marchand, C.; Neamati, N.; Pommier, Y. In vitro human immuno-
deficiency virus type 1 integrase assays. Methods Enzymol. 2001, 340
(Drug-Nucleic Acid Interactions), 624–633.
(36) Semenova, E. A.; Johnson, A. A.; Marchand, C.; Davis, D. A.;
Yarchoan, R.; Pommier, Y. Preferential inhibition of the magnesium-
dependent strand transfer reaction of HIV-1 integrase by R-hydrox-
ytropolones. Mol. Pharmacol. 2006, 69, 1454–1460.
(15) Fuji, M.; Matsushita, S.; Mikamiyama, H. Antiviral agents containing
nitrogen-containing heteroaromatic compounds. Japanese patent ap-
plication: JP 2004244320, 2004; Chem. Abstr. AN 2004: 716288.
(16) Kong, L. C. C.; Zhang, M.-Q.; Halab, L.; Nguyen-Ba, N.; Liu, B. A
preparation of pyridinecarboxamide derivatives, useful for inhibiting
HIV integrase. PCT Application: WO 2005042524, 2005; Chem. Abstr.
AN 2005: 409512.
(17) Hong, H.; Neamati, N.; Wang, S.; Nicklaus, M. C.; Mazumder, A.;
Zhao, H.; Burke, T. R., Jr.; Pommier, Y.; Milne, G. W. A. Discovery
of HIV-1 integrase inhibitors by pharmacophore searching. J. Med.
Chem. 1997, 40, 930–936.
(18) Zhao, H.; Neamati, N.; Sunder, S.; Hong, H. X.; Wang, S. M.; Milne,
G. W. A.; Pommier, Y.; Burke, T. R. Hydrazide-containing inhibitors
of HIV-1 integrase. J. Med. Chem. 1997, 40, 937–941.
(19) Neamati, N.; Hong, H. X.; Owen, J. M.; Sunder, S.; Winslow, H. E.;
Christensen, J. L.; Zhao, H.; Burke, T. R.; Milne, G. W. A.; Pommier,
Y. Salicylhydrazine-containing inhibitors of HIV-1 integrase: Implica-
tion for a selective chelation in the integrase active site. J. Med. Chem.
1998, 41 (17), 3202–3209.
(37) Napolitano, E.; Spinelli, G.; Fiaschi, R.; Marsili, A. Regioselective
total synthesis of (()-berberastine. J. Chem. Soc., Perkin Trans 1 1987,
12, 2565–2568.
(38) Baudart, M. G.; Hennequin, L. F. Synthesis and biological-activity of
C-3′-ortho-dihydroxyphthalimido cephalosporins. J. Antibiot. 1993,
46, 1458–1470.
(20) Neamati, N.; Lin, Z.; Karki, R. G.; Orr, A.; Cowansage, K.; Strumberg,
D.; Pais, G. C. G.; Voigt, J. H.; Nicklaus, M. C.; Winslow, H. E.;
Zhao, H.; Turpin, J. A.; Yi, J.; Skalka, A. M.; Burke, T. R., Jr.;
JM070715D